As shown in the articles and studies referenced above, nesfatin-1 has emerged as a potential regulator of energy balance, food intake, and glucose metabolism, making it a promising target for the treatment of metabolic disorders [38,58]. The gene discussed is NUCB2; the disease is metabolic disease.